CORT
NASDAQ · Pharmaceuticals
Corcept Therapeutics Inc
$110.29
-4.57 (-3.98%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+37.86%
YTD
+188.72%
Open$116.80
Previous Close$114.86
Day High$117.90
Day Low$108.41
52W High$126.38
52W Low$28.66
Volume—
Avg Volume904.1K
Market Cap11.92B
P/E Ratio216.05
EPS$0.43
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$53.13
Above
SMA 200
$69.00
Above
RSI (14)
26
Oversold
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
12 analysts
Price Target
-7.2% upside
Current
$110.29
$110.29
Target
$102.33
$102.33
$62.31
$102.33 avg
$121.34
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 685.96M | 554.36M | 785.70M |
| Net Income | 89.78M | 65.30M | 178.89M |
| Profit Margin | 13.1% | 12.4% | 22.8% |
| EBITDA | 41.39M | 31.78M | 255.84M |
| Free Cash Flow | — | — | 116.31M |
| Rev Growth | +23.7% | +23.7% | +17.7% |
| Debt/Equity | — | — | 0.15 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,152.93 | +0.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.99 | -0.09% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $146.87 | -0.19% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.66 | +0.07% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $63.06 | +0.35% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.40 | -2.22% | 11.5 | 30.15B |